Kurowska Patrycja, Mlyczyńska Ewa, Dawid Monika, Grzesiak Małgorzata, Dupont Joelle, Rak Agnieszka
Department of Physiology and Toxicology of Reproduction, Jagiellonian University in Krakow, Krakow, Poland.
Department of Endocrinology, Jagiellonian University in Krakow, Krakow, Poland.
J Endocrinol. 2020 Dec;247(3):283-294. doi: 10.1530/JOE-20-0332.
Vaspin, visceral adipose tissue-derived serine protease inhibitor, plays important roles in inflammation, obesity, and glucose metabolism. Our recent research has shown the expression and role of vaspin in the function of ovarian follicles. However, whether vaspin regulates steroidogenesis and luteolysis in the corpus luteum (CL) is still unknown. The aim of this study was first to determine the expression of vaspin and its receptor GRP78 in porcine CL at the early, middle, and late stages of the luteal phase. Next, we investigated the hormonal regulation of vaspin levels in luteal cells in response to luteinizing hormone (LH), progesterone (P4), and prostaglandin PGE2 and PGF2α. Finally, we determined vaspin's direct impact on luteal cells steroidogenesis, luteolysis and kinases phosphorylation. Our results are the first to show higher vaspin/GRP78 expression in middle and late vs early stages; immunohistochemistry showed cytoplasmic vaspin/GRP78 localization in small and large luteal cells. In vitro, we found that LH, P4, PGE2, and PGF2α significantly decreased vaspin levels. Furthermore, vaspin stimulated steroidogenesis by the activation of the GRP78 receptor and protein kinase A (PKA). Also, vaspin increased the ratio of luteotropic PGE2 to luteolytic PGF2α secretion via GRP78 and mitogen-activated kinase (MAP3/1). Moreover, vaspin, in a dose-dependent manner, decreased GRP78 expression, while it, in a time-dependent manner, increased kinases PKA and MAPK3/1 phosphorylation. Taken together, we found that vaspin/GRP78 expression depends on the luteal phase stage and vaspin affects luteal cells endocrinology, indicating that vaspin is a new regulator of luteal cells steroidogenesis and CL formation.
内脏脂肪组织衍生的丝氨酸蛋白酶抑制剂内脏脂肪素(vaspin)在炎症、肥胖和糖代谢中发挥着重要作用。我们最近的研究表明了内脏脂肪素在卵泡功能中的表达及作用。然而,内脏脂肪素是否调节黄体(CL)中的类固醇生成和黄体溶解仍不清楚。本研究的目的首先是确定在黄体期早期、中期和晚期猪黄体中内脏脂肪素及其受体GRP78的表达。接下来,我们研究了黄体细胞中内脏脂肪素水平对促黄体生成素(LH)、孕酮(P4)、前列腺素PGE2和PGF2α的激素调节反应。最后,我们确定了内脏脂肪素对黄体细胞类固醇生成、黄体溶解和激酶磷酸化的直接影响。我们的结果首次表明,与早期相比,中期和晚期内脏脂肪素/GRP78表达更高;免疫组织化学显示内脏脂肪素/GRP78定位于小黄体细胞和大黄体细胞的细胞质中。在体外,我们发现LH、P4、PGE2和PGF2α显著降低了内脏脂肪素水平。此外,内脏脂肪素通过激活GRP78受体和蛋白激酶A(PKA)刺激类固醇生成。而且,内脏脂肪素通过GRP78和丝裂原活化激酶(MAP3/1)增加促黄体生成的PGE2与促黄体溶解的PGF2α分泌的比例。此外,内脏脂肪素以剂量依赖的方式降低GRP78表达,而以时间依赖的方式增加激酶PKA和MAPK3/1的磷酸化。综上所述,我们发现内脏脂肪素/GRP78的表达取决于黄体期阶段,且内脏脂肪素影响黄体细胞内分泌,表明内脏脂肪素是黄体细胞类固醇生成和黄体形成的新调节因子。